FACTBOX-Vaccines delivered under COVAX sharing scheme for poorer countries

(Sorts tables alphabetically; updates Colombia, Ghana, Indonesia, Ivory Coast, Jamaica, Mali, Mongolia, Nicaragua, Pakistan, Paraguay, Peru, Senegal, Sierra Leone, South Sudan, Togo, Tunisia, Uzbekistan, Vietnam) Sept 15 (Reuters) - The COVAX facility, backed by the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), has delivered over 272 million COVID-19 vaccine doses to 141 countries, GAVI data shows, but in September the organizations running the facility had to cut their 2021 delivery target by nearly 30% to 1.425 billion doses. The following tables list countries that have received vaccines under the scheme, sorted alphabetically: AFRICA & MIDDLE EAST COUNTRY LATEST DELIVERY DATE VACCINE TYPE POPULATION TOTAL DELIVERED DELIVERY Algeria 567,600 August 31 Sinovac 44 million 932,400 Angola 586,170 August 24 Pfizer/BioNTech 33 million 1.4 million Benin 302,400 July 26 J&J 12 million 446,400 Botswana 81,900 August 19 Pfizer/BioNTech 2.5 million 158,700 Burkina Faso 151,200 August 1 J&J 21 million 417,400 Cameroon 303,050 July 21 J&J 27 million 694,250 Cape Verde 24,000 March 12 AstraZeneca/Oxford 556,000 24,000 Central 302,400 July 22 J&J 4.8 million 302,400 African Republic Chad 100,620 June 23 Pfizer/BioNTech 16 million 100,620 Comoros 12,000 April 12 AstraZeneca/Oxford 870,000 12,000 Islands Congo 302,400 August 27 J&J 5.5 million 302,400 Democratic 250,320 September 6 Moderna 90 million 2.0 million Republic of Congo Djibouti 151,200 July 17 J&J 988,000 175,200 Egypt 299,700 August 16 AstraZeneca/Oxford 102 million 2.9 million Eswatini 302,400 July 27 J&J 1.1 million 328,800 Ethiopia 499,200 August 17 AstraZeneca/Oxford 115 million 4.3 million Gambia 38,400 August 22 AstraZeneca/Oxford 2.4 million 376,800 Ghana 487,600 September 14 AstraZeneca/Oxford 31 million 3.0 million Guinea 130,560 August 18 AstraZeneca/Oxford 13 million 324,960 Guinea-Bissau 28,800 August 18 AstraZeneca/Oxford 2.0 million 360,000 Iran 1.0 million July 30 AstraZeneca/Oxford 84 million 2.5 million Iraq 500,000 August 14 Pfizer/BioNTech 40 million 836,000 Ivory Coast 373,230 September 11 Pfizer/BioNTech 26 million 2.1 million Jordan 146,400 June 3 AstraZeneca/Oxford 10 million 436,800 Kenya 880,320 September 6 Moderna 54 million 4.2 million Lebanon 33,600 March 24 AstraZeneca/Oxford 6.8 million 33,600 Lesotho 302,400 July 23 J&J 2.1 million 374,400 Liberia 96,000 August 20 AstraZeneca/Oxford 5.1 million 494,400 Libya 54,600 June 24 Pfizer/BioNTech 6.9 million 229,800 Madagascar 302,750 July 27 J&J 28 million 552,750 Malawi 115,200 August 20 AstraZeneca/Oxford 19 million 1.1 million Mali 79,200 September 11 AstraZeneca/Oxford 20 million 626,400 Mauritania 302,400 August 1 J&J 4.6 million 403,100 Morocco 302,400 July 25 J&J 37 million 302,400 Mozambique 302,400 July 26 J&J 31 million 686,400 Namibia 43,000 May 24 AstraZeneca/Oxford 2.5 million 67,000 Niger 100,800 September 2 AstraZeneca/Oxford 24 million 758,200 Nigeria 4.0 million August 2 Moderna 206 million 7.9 million Palestinian 500,000 August 24 Moderna 4.7 million 664,400 Territories Rwanda 489,060 August 18 Pfizer/BioNTech 13 million 1.1 million Sao Tome and 24,000 March 3 AstraZeneca/Oxford 219,000 24,000 Principe Senegal 405,600 September 10 AstraZeneca/Oxford 17 million 1.4 million Seychelles 35,100 September 8 Pfizer/BioNTech 98,460 35,100 Sierra Leone 113,490 September 13 AstraZeneca/Oxford 8.0 million 305,490 Somalia 302,400 August 12 J&J 16 million 710,400 South Africa 5.6 million July 31 Pfizer/BioNTech 59 million 5.6 million South Sudan 152,950 September 15 J&J 11 million 344,450 Sudan 218,400 August 27 AstraZeneca/Oxford 44 million 1.6 million Syria 256,800 April 22 AstraZeneca/Oxford 17 million 256,800 Tanzania 1.0 million July 24 J&J 60 million 1.0 million Togo 117,000 September 13 Pfizer/BioNTech 8.3 million 511,660 Tunisia 687,960 September 10 Pfizer/BioNTech 12 million 2.7 million Uganda 647,070 September 6 Moderna 46 million 2.1 million Yemen 151,200 August 30 J&J 30 million 511,200 Zambia 119,200 August 13 AstraZeneca/Oxford 18 million 877,600 EUROPE COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL DELIVERY DATE DELIVERED Albania 40,800 June 2 AstraZeneca/Oxford 2.8 million 120,000 Armenia 187,200 September 5 AstraZeneca/Oxford 3.0 million 261,200 Azerbaijan 84,000 April 4 AstraZeneca/Oxford 10 million 84,000 Bosnia 32,760 May 10 Pfizer/BioNTech 3.3 million 82,560 Georgia 43,200 March 13 AstraZeneca/Oxford 3.7 million 43,200 Kosovo 503,100 September 6 Pfizer/BioNTech 1.8 million 701,220 Moldova 301,000 August 1 J&J 2.6 million 644,000 Montenegro 24,000 March 28 AstraZeneca/Oxford 622,000 24,000 North 38,400 May 14 AstraZeneca/Oxford 2.1 million 62,400 Macedonia Serbia 115,200 August 25 AstraZeneca/Oxford 6.9 million 292,800 Ukraine 188,000 August 29 Pfizer/BioNTech 44 million 3.5 million ASIA & PACIFIC COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL DELIVERY DATE DELIVERED Afghanistan 144,000 August 8 AstraZeneca/Oxford 39 million 4.2 million Bangladesh 781,440 August 21 AstraZeneca/Oxford 165 million 11.5 million Brunei 24,000 April 2 AstraZeneca/Oxford 437,000 24,000 Cambodia 609,600 August 2 J&J 17 million 1.4 million East Timor 168,000 August 13 AstraZeneca/Oxford 1.3 million 292,800 Fiji 56,000 August 24 AstraZeneca/Oxford 896,000 252,080 Indonesia 358,700 September 11 AstraZeneca/Oxford 274 million 19.5 million Kiribati 56,000 August 21 AstraZeneca/Oxford 119,000 104,000 Kyrgyzstan 226,500 July 31 AstraZeneca/Oxford 6.6 million 226,500 Laos 616,820 August 5 AstraZeneca/Oxford 7.3 million 1.8 million Malaysia 559,200 May 21 AstraZeneca/Oxford 32 million 828,000 Maldives 112,000 August 23 AstraZeneca/Oxford 541,000 252,700 Mongolia 188,370 September 9 Pfizer/BioNTech 3.3 million 379,490 Nauru 7,200 April 2 AstraZeneca/Oxford 10,830 7,200 Nepal 1.6 million August 23 AstraZeneca/Oxford 29 million 3.4 million Pakistan 320,580 September 13 Pfizer/BioNTech 221 million 9.4 million Papua New 302,400 August 6 J&J 8.9 million 580,400 Guinea Philippines 3.0 million August 3 Moderna 110 million 13.2 million Samoa 112,000 August 23 AstraZeneca/Oxford 198,410 136,000 Solomon 56,000 August 29 AstraZeneca/Oxford 687,000 108,800 Islands Sri Lanka 100,000 August 28 Pfizer/BioNTech 22 million 3.2 million Tajikistan 128,000 August 10 AstraZeneca/Oxford 9.5 million 1.8 million Tonga 36,800 August 25 AstraZeneca/Oxford 106,000 60,800 Tuvalu 4,800 April 8 AstraZeneca/Oxford 11,800 4,800 Uzbekistan 1.2 million September 14 Pfizer/BioNTech 34 million 5.2 million Vanuatu 24,000 May 19 AstraZeneca/Oxford 307,000 24,000 Vietnam 1.5 million September 14 AstraZeneca/Oxford 97 million 11.7 million AMERICAS COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL DELIVERY DATE DELIVERED Antigua and 16,800 June 9 AstraZeneca/Oxford 98,000 40,800 Barbuda Argentina 864,000 April 18 AstraZeneca/Oxford 45 million 1,082,000 Bahamas 33,600 August 3 AstraZeneca/Oxford 393,000 67,200 Barbados 33,600 August 24 AstraZeneca/Oxford 287,000 100,800 Belize 33,600 August 3 AstraZeneca/Oxford 398,000 100,800 Bermuda 9,600 April 6 AstraZeneca/Oxford 64,000 9,600 Bolivia 153,600 August 13 AstraZeneca/Oxford 12 million 1.6 million Brazil 441,600 July 30 AstraZeneca/Oxford 213 million 8.9 million Chile 331,000 May 20 AstraZeneca/Oxford 19 million 489,400 Colombia 2.1 million September 13 Sinovac 51 million 6.4 million Costa Rica 86,400 September 5 AstraZeneca/Oxford 5.1 million 398,550 Dominica 28,800 April 6 AstraZeneca/Oxford 72,000 28,800 Dominican 184,800 August 27 AstraZeneca/Oxford 11 million 463,200 Republic Ecuador 101,760 August 16 AstraZeneca/Oxford 18 million 857,760 El Salvador 188,370 August 27 Pfizer/BioNTech 6.5 million 3.6 million Grenada 21,600 May 26 AstraZeneca/Oxford 113,000 45,600 Guatemala 363,100 September 5 AstraZeneca/Oxford 17 million 1.8 million Guyana 19,200 August 14 AstraZeneca/Oxford 787,000 120,000 Haiti 500,000 July 14 Moderna 11 million 500,000 Honduras 188,370 August 25 Pfizer/BioNTech 9.9 million 3.6 million Jamaica 100,800 September 14 AstraZeneca/Oxford 3.0 million 225,600 Mexico 2.2 million May 27 AstraZeneca/Oxford 129 million 3.3 million Nicaragua 199,200 September 11 AstraZeneca/Oxford 6.6 million 468,600 Panama 74,400 May 11 AstraZeneca/Oxford 4.3 million 74,400 Paraguay 306,900 September 12 AstraZeneca/Oxford 7.1 million 865,140 Peru 146,400 September 14 AstraZeneca/Oxford 33 million 2.2 million Saint Kitts and 21,600 April 7 AstraZeneca/Oxford 53,000 21,600 Nevis Saint Lucia 24,000 September 1 AstraZeneca/Oxford 184,000 74,400 Saint Vincent 21,600 May 25 AstraZeneca/Oxford 111,000 45,600 and the Grenadines Suriname 26,400 August 9 AstraZeneca/Oxford 587,000 79,200 Trinidad and 33,600 August 11 AstraZeneca/Oxford 1.4 million 101,200 Tobago Uruguay 50,400 September 1 AstraZeneca/Oxford 3.5 million 148,800 Venezuela 693,600 September 6 Sinovac 28 million 693,600 Sources: WHO, UNICEF, GAVI, releases from local authorities (Reporting by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou in Gdansk; editing by Milla Nissi, William Maclean)

09/15/2021 14:21

News, Photo and Web Search